The Company has not created provision for Interest on MSME Dues for FY 2024-25, 2023-24 & 2022-23 as per its understanding with the creditors.

9. The company has not paid any dividend during the restatement period. There are no proposed or arrears of dividend to be distributed to equity or preference shareholders for the period.

10. The Company has complied with the number of layers prescribed under clause (87) of section 2 of the Act read with the Companies (Restriction on number of Layers) Rules, 2017.

11. During the period of restatement, the Company is not part of any Scheme(s) of arrangements.

## 12. Corporate Social Responsibility (CSR) activities

As per Section 135 of the Companies Act, 2013, the Company needs to be spent 2% of average net profits for previous three financial years, calculated as per Section 198 of the Companies Act, 2013 for CSR activities like promoting sports, education, medical and other social projects. All these activities are covered under Schedule VII to the Companies Act, 2013. The details of amount spent are:

(Amount in Rs. Lakhs)

<table><thead><tr><th>Particulars</th><th>For the year ended March 31, 2025</th><th>For the year ended March 31, 2024</th><th>For the year ended March 31, 2023</th></tr></thead><tbody><tr><td>Amount required to be spent by the Company during the period/year</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Amount of expenditure incurred</td><td>-</td><td>-</td><td>-</td></tr><tr><td>(Excess)/Shortfall at the end of the year</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Total of previous years shortfall</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Reason for shortfall</td><td>-</td><td>NA</td><td>NA</td></tr><tr><td>Nature of CSR Activities</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>Details of related party transactions e.g. contribution to a trust controlled by the Company in relation to CSR expenditure as per relevant Accounting Standard</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>Where a provision is made with respect to a liability incurred by entering into a contractual obligation, the movements in the provision</td><td>NA</td><td>NA</td><td>NA</td></tr></tbody></table>

## 13. Utilisation of Borrowed funds and share premium:

a) As stated & confirmed by the Board of Directors, the company has not advanced or loaned or invested funds (either borrowed funds or share premium or any other sources or kind of funds) to any other person(s) or entity(ies), including foreign entities (Intermediaries) with the understanding (whether recorded in writing or otherwise) that the Intermediary shall:

i. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the company (Ultimate Beneficiaries) or

ii. provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries;

b) As stated & confirmed by the Board of Directors, the company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether recorded in writing or otherwise) that the company shall:

i. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or

ii. provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries"

14. During the period of restatement, company has no Extraordinary Items to be disclosed in accordance with the requirements of AS - 5 "Net Profit or Loss for the Period, Prior Period Items and Changes in Accounting Policies.